Forte Biosciences, Inc.(FBRX)
Biotechnology
Immunology & Autoimmune Biotech
Recent Insider Trades
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-01-02 | Riley Antony A CHIEF FINANCIAL OFFICER | Purchase | +9,680 | +30.19%41,741 | $26.33 | $254,833 | View SEC filing | |
| 2024-11-22 | Riley Antony A CHIEF FINANCIAL OFFICER | Purchase | +22,514 | +272.50%30,776 | $5.55 | $124,998 | View SEC filing | |
| 2023-12-20 | Wagner Paul A. See Remarks | Purchase | +10,000 | +0.55%1,823,236 | $0.75 | $7,525 | View SEC filing | |
| 2023-12-15 | Wagner Paul A. See Remarks | Purchase | +20,520 | +1.14%1,813,236 | $0.71 | $14,551 | View SEC filing | |
| 2023-12-12 | Wagner Paul A. See Remarks | Purchase | +29,776 | +1.69%1,792,716 | $0.65 | $19,276 | View SEC filing | |
| 2023-12-08 | Wagner Paul A. See Remarks | Purchase | +51,203 | +2.99%1,762,940 | $0.60 | $30,468 | View SEC filing | |
| 2023-11-22 | Wagner Paul A. See Remarks | Purchase | +7,366 | +0.43%1,711,737 | $0.44 | $3,220 | View SEC filing | |
| 2022-12-19 | Wagner Paul A. See Remarks | Purchase | +100,000 | +7.82%1,379,049 | $1.05 | $104,672 | View SEC filing | |
| 2021-09-08 | Wagner Paul A. See Remarks | Sale | -1,000,000 | -43.88%1,279,049 | $4.35 | $4,347,100 | View SEC filing | |
| 2021-09-07 | Riley Antony A Chief Financial Officer | Sale | -25,000 | -69.32%11,065 | $4.24 | $106,105 | View SEC filing | |
| 2020-06-30 | Riley Antony A Chief Financial Officer | Purchase | +6,700 | +22.82%36,065 | $14.39 | $96,445 | View SEC filing | |
| 2020-06-29 | Wagner Paul A. See Remarks | Purchase | +7,000 | +0.31%2,279,049 | $14.48 | $101,356 | View SEC filing | |
| 2020-04-14 | Oliveira Steven Michael 10% Owner | Purchase | +74,301 | +1.83%4,139,450 | $1.19 | $88,418 | View SEC filing | |
| 2020-03-03 | Oliveira Steven Michael 10% Owner | Purchase | +65,149 | +2.38%2,799,149 | $1.35 | $87,756 | View SEC filing | |
| 2019-06-03 | Hasnain Faheem Director | Purchase | +43,000 | +21.20%245,857 | $4.66 | $200,315 | View SEC filing | |
| 2019-05-29 | FOLETTA MARK G EVP & Chief Financial Officer | Purchase | +5,000 | +49.79%15,042 | $4.29 | $21,475 | View SEC filing | |
| 2019-05-29 | Duvall Martin J Chief Executive Officer | Purchase | +5,000 | +58.11%13,605 | $4.34 | $21,679 | View SEC filing | |
| 2019-05-29 | GRUBER HARRY E President, Science&Innovation | Purchase | +5,000 | +105.40%9,744 | $4.56 | $22,783 | View SEC filing | |
| 2017-04-21 | Das Asha SVP & Chief Medical Officer | Purchase | +2,500 | +100.00%2,500 | $10.00 | $25,000 | View SEC filing | |
| 2017-04-21 | FOLETTA MARK G EVP & Chief Financial Officer | Purchase | +5,000 | +100.00%5,000 | $10.00 | $50,000 | View SEC filing | |
| 2017-04-21 | GRUBER HARRY E President, Research & Devel | Purchase | +25,000 | +6.37%417,753 | $10.00 | $250,000 | View SEC filing | |
| 2017-04-21 | SCHIMMEL PAUL Director | Purchase | +10,000 | +276.01%13,623 | $10.00 | $100,000 | View SEC filing | |
| 2017-04-21 | Hasnain Faheem Director | Purchase | +100,000 | +97.22%202,857 | $10.00 | $1,000,000 | View SEC filing |
1-23 of 23
Page 1 of 1